Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Cancer Immunology Research|January 19, 2020
Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular CarcinomaSai Arun Batra, Purva Rathi, Linjie Guo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.Advances in Cell and Gene Therapy|April 8, 2021
Engineering Oncolytic Vaccinia Virus to redirect Macrophages to Tumor CellsFelicia Cao, Phuong Nguyen, Bangxing Hong, et al.Journal of the National Cancer Institute|May 1, 2008
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapyXiaoxian Li, Michael T Lewis, Jian Huang, et al.Science Signaling|September 17, 2015
An essential role for Gα(i2) in Smoothened-stimulated epithelial cell proliferation in the mammary glandHugo Villanueva, Adriana P Visbal, Nadine F Obeid, et al.Nature Communications|November 14, 2018
Publisher Correction: EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cellsDeepika Neelakantan, Hengbo Zhou, Michael U J Oliphant, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
Reduced dose and intermittent treatment with lapatinib and trastuzumab for potent blockade of the HER pathway in HER2/neu-overexpressing breast tumor xenograftsMothaffar F Rimawi, Lisa S Wiechmann, Yen-Chao Wang, et al.Nature Communications|June 13, 2017
EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cellsDeepika Neelakantan, Hengbo Zhou, Michael U J Oliphant, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancersBhuvanesh Dave, Ilenia Migliaccio, M Carolina Gutierrez, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 17, 2012
T cells redirected to EphA2 for the immunotherapy of glioblastomaKevin K H Chow, Swati Naik, Sunitha Kakarla, et al.Pageof 7